West Sacramento CA – Gemini Bioproducts a leading supplier of cell culture reagents and process liquids, a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, today announced the opening of a new, state-of-the-art cGMP manufacturing facility and warehouse in West Sacramento, California.
GeminiBio’s new 32,000 square feet fully validated cGMP facility consists of segregated animal origin (AO) product ISO 7 manufacturing suites and segregated AO/ animal origin free (AOF) raw material and finished good warehousing. This new cGMP warehouse includes temperature mapped and validated storage conditions, including -20C, 2-8C, and controlled room temperature (CRT).
Keep Reading This Article at The Davis Vanguard